[Molecular genetic mechanisms of drug resistance in prostate cancer]

Drug resistance and especially cross-resistance are the most important problems of therapy of prostate cancer. Drug resistance mechanisms, including ligand-dependent (requiring the presence of androgens in the cell) and independent (not requiring androgens) ones, are reviewed.

The mechanisms are mainly based on mutations of the androgen receptor (AR) gene, expression of aberrant constitutively active AR splice variants, and upregulation of androgen synthesis genes.

Molekuliarnaia biologiia. 0000 [Epub]

G S Krasnov, A A Dmitriev, A F Sadritdinova, N N Volchenko, E N Slavnova, T V Danilova, A V Snezhkina, N V Melnikova, M S Fedorova, V A Lakunina, A A Belova, K M Nyushko, B Y Alekseev, A D Kaprin, A V Kudryavtseva

Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia. , Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia. , Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia. , Herzen Moscow Cancer Research Institute, Ministry of Health of the Russian Federation, Moscow, 125284, Russia. , Herzen Moscow Cancer Research Institute, Ministry of Health of the Russian Federation, Moscow, 125284, Russia. , Herzen Moscow Cancer Research Institute, Ministry of Health of the Russian Federation, Moscow, 125284, Russia. , Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia. , Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia. , Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia. , Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia. , Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia. , Herzen Moscow Cancer Research Institute, Ministry of Health of the Russian Federation, Moscow, 125284, Russia. , Herzen Moscow Cancer Research Institute, Ministry of Health of the Russian Federation, Moscow, 125284, Russia. , Herzen Moscow Cancer Research Institute, Ministry of Health of the Russian Federation, Moscow, 125284, Russia. , Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991, Russia.

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe